journal article·2023-11-08

FNIII14 Peptide-Enriched Membrane Nanocarrier to Disrupt Stromal Barriers through Reversing CAFs for Augmenting Drug Penetration in Tumors

Zhenan Liu, Ping Ji, Hanzhe Liu, Lili Yu, Shi-Man Zhang, Pan Liu, Xian-Zheng Zhang, Guo-Feng Luo, Zhengjun Shang

Nano Letters· Volume 23· Issue 21
Publisher page

Abstract

Given the key roles of cancer associated fibroblasts (CAFs) in shaping tumor stroma, this study shows a CAF-associated ITGB1-inactivating peptide-enriched membrane nanodelivery system (designated as PMNPs-D) to simultaneously target CAFs and tumor cells for boosted chemotherapy through promoted drug perfusion. In the structure of PMNPs-D, the PLGA-based inner core is loaded with the chemotherapeutic drug doxorubicin, and the outer surface is cloaked by hybrid biomembranes with the insertion of integrin β1 (ITGB1) inhibiting peptide (i.e., FNIII14). After prolonged blood circulation and actively targeting in tumor sites, PMNPs-D can respond to CAF-overexpressed fibroblast activation protein-α (FAP-α) to trigger the release of FNIII14, which will bind to ITGB1 and inhibit CAFs' biological function in producing the stromal matrix, thereby loosening the condensed stromal structure and enhancing the permeability of nanotherapeutics in tumors. As a result, this tailor-designed nanosystem shows substantial tumor inhibition and metastasis retardation in aggressive adenoid cystic carcinoma (ACC) tumor-harboring mice.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Peptidase Inhibition and Analysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, P. R. China

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China

Funding

National Key Research and Development Program of China · Health and Family Planning Commission of Hubei Province · National Natural Science Foundation of China

References (41)

Show source-provided references
1. 10.1016/j.oraloncology.2015.04.00510.1016/j.oraloncology.2015.04.005 ↗
2. 10.1038/ng.264310.1038/ng.2643 ↗
3. 10.1002/hed.2340510.1002/hed.23405 ↗
4. 10.1371/journal.pone.015024710.1371/journal.pone.0150247 ↗
5. 10.1016/j.oraloncology.2006.01.00110.1016/j.oraloncology.2006.01.001 ↗
6. 10.1021/acs.chemrev.7b0025810.1021/acs.chemrev.7b00258 ↗
7. 10.1073/pnas.152208011310.1073/pnas.1522080113 ↗
8. 10.1039/D1CS01148K10.1039/D1CS01148K ↗
9. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
10. 10.1002/anie.20221740810.1002/anie.202217408 ↗
11. 10.1038/s41551-017-0115-810.1038/s41551-017-0115-8 ↗
12. 10.1038/s41565-022-01122-310.1038/s41565-022-01122-3 ↗
13. 10.1021/acsnano.7b0102610.1021/acsnano.7b01026 ↗
14. 10.1097/IOP.000000000000207110.1097/IOP.0000000000002071 ↗
15. 10.1002/adfm.20180184010.1002/adfm.201801840 ↗
16. 10.1021/acs.nanolett.6b0082010.1021/acs.nanolett.6b00820 ↗
17. 10.1016/j.addr.2015.11.01410.1016/j.addr.2015.11.014 ↗
18. 10.1002/adfm.20190244010.1002/adfm.201902440 ↗
19. 10.1016/j.biomaterials.2018.04.03910.1016/j.biomaterials.2018.04.039 ↗
20. 10.1021/acs.nanolett.6b0006810.1021/acs.nanolett.6b00068 ↗
21. 10.1038/s41575-019-0115-010.1038/s41575-019-0115-0 ↗
22. 10.1038/s41568-019-0238-110.1038/s41568-019-0238-1 ↗
23. 10.1186/s12943-022-01670-110.1186/s12943-022-01670-1 ↗
24. 10.1038/s41571-018-0007-110.1038/s41571-018-0007-1 ↗
25. 10.1111/odi.1420310.1111/odi.14203 ↗
26. 10.1038/s41388-023-02642-510.1038/s41388-023-02642-5 ↗
27. 10.1016/S0092-8674(02)00971-610.1016/S0092-8674(02)00971-6 ↗
28. 10.1016/j.devcel.2015.05.00510.1016/j.devcel.2015.05.005 ↗
29. 10.1007/s00441-009-0834-610.1007/s00441-009-0834-6 ↗
30. 10.1016/j.addr.2018.01.02010.1016/j.addr.2018.01.020 ↗
31. 10.3390/cancers1414337710.3390/cancers14143377 ↗
32. 10.1242/jcs.07067210.1242/jcs.070672 ↗
33. 10.1002/1878-0261.1293710.1002/1878-0261.12937 ↗
34. 10.1007/s12079-022-00673-310.1007/s12079-022-00673-3 ↗
35. 10.1186/s12943-019-1101-410.1186/s12943-019-1101-4 ↗
36. 10.3390/cancers1420498310.3390/cancers14204983 ↗
37. 10.1016/j.matbio.2019.12.00110.1016/j.matbio.2019.12.001 ↗
38. 10.3390/encyclopedia102002910.3390/encyclopedia1020029 ↗
39. Kato R. · Clin. Cancer Res. · 2002 · 8 · 2455
40. 10.1021/nl500618u10.1021/nl500618u ↗
41. 10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗